Fleur B Nijdam

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Simultaneous Determination

Gas Chromatography

Electronic Health Record

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Frank Klont, Fleur B Nijdam, Stephan J L Bakker, Pekka Keski-Rahkonen, Gérard Hopfgartner, TransplantLines Investigators
High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification. The Analyst 149 (4) (2024)
Frank Klont, Fleur B Nijdam, Stephan J L Bakker, Pekka Keski-Rahkonen, Gérard Hopfgartner, TransplantLines Investigators
High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification. The Analyst (2024)
Frank Klont, Fleur B Nijdam, Stephan J L Bakker, Pekka Keski-Rahkonen, Gérard Hopfgartner, TransplantLines Investigators
High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification. The Analyst 149 (4) (2024)
Frank Klont, Fleur B Nijdam, Stephan J L Bakker, Pekka Keski-Rahkonen, Gérard Hopfgartner, TransplantLines Investigators
High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification. The Analyst (2024)
Frank Klont, Fleur B Nijdam, Stephan J L Bakker, Pekka Keski-Rahkonen, Gérard Hopfgartner, TransplantLines Investigators
High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification. The Analyst 149 (4) (2024)
Frank Klont, Fleur B Nijdam, Stephan J L Bakker, Pekka Keski-Rahkonen, Gérard Hopfgartner, TransplantLines Investigators
High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification. The Analyst 149 (4) (2024)
Frank Klont, Fleur B Nijdam, Stephan J L Bakker, Pekka Keski-Rahkonen, Gérard Hopfgartner, TransplantLines Investigators
High-abundance peaks and peak clusters associate with pharmaceutical polymers and excipients in urinary untargeted clinical metabolomics data: exploration of their origin and possible impact on label-free quantification. The Analyst 149 (4) (2024)